综述

儿童脑肿瘤氨基酸PET显像的研究进展

  • 刘子豪 ,
  • 唐文芳 ,
  • 王辉
展开
  • 上海交通大学医学院附属新华医院核医学科,上海 200092
刘子豪(1994—),男,博士生;电子信箱:liuzihao2021@163.com

网络出版日期: 2021-08-03

基金资助

国家自然科学基金(51673116)

Research progress in amino acid PET imaging of pediatric brain tumors

  • Zi-hao LIU ,
  • Wen-fang TANG ,
  • Hui WANG
Expand
  • Department of Nuclear Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Online published: 2021-08-03

Supported by

National Natural Science Foundation of China(51673116)

摘要

脑肿瘤是儿童肿瘤中最常见的实体肿瘤,也是儿童肿瘤致死的首要原因。常规磁共振成像(magnetic resonance imaging,MRI)在儿童脑肿瘤的诊断、治疗管理及预后评估等方面存在一定的不足。正电子发射断层显像(positron emission tomography,PET)是反映肿瘤生物学特征的成像技术,利用特定放射性药物的生物学分布特征,可以提供肿瘤的不同功能代谢信息,与常规MRI的形态学信息进行互补。氨基酸PET显像利用放射性核素标记的各种氨基酸在人体内的代谢情况,进行肿瘤的功能显像。氨基酸PET显像在儿童脑肿瘤的诊断与分级、活检计划制订、预后评估、复发监测与疗效评估等方面具有重要的作用。该文就近年来氨基酸PET/CT与PET/MRI在胶质瘤、神经上皮肿瘤等儿童脑肿瘤中的临床应用进行综述。

本文引用格式

刘子豪 , 唐文芳 , 王辉 . 儿童脑肿瘤氨基酸PET显像的研究进展[J]. 上海交通大学学报(医学版), 2021 , 41(7) : 949 -952 . DOI: 10.3969/j.issn.1674-8115.2021.07.016

Abstract

Brain tumor is the most common solid tumor in pediatric tumors with the highest rate of mortality. Conventional magnetic resonance imaging (MRI) indicates some limitations in diagnosis, surgical management and prognosis for pediatric brain tumors. Positron-emission tomography (PET) is an imaging technology that reflects the biological characteristics of tumors. By using the biological distribution of specific radiopharmaceuticals, PET can provide different metabolic information of the tumor and complement the morphological information of conventional MRI. Amino acid PET imaging uses the metabolism of radiolabeled amino acids in human to perform functional imaging of tumors. The benefits of amino acid PET imaging include diagnosis and grading, biopsy planning, prognosis, recurrence monitoring, and efficacy evaluation. This paper reviews the application of amino acid PET/CT and PET/MRI to pediatric brain tumors.

参考文献

1 Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017[J]. Neuro Oncol, 2020, 22(12 ): iv1-iv96.
2 Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820.
3 梅芬, 邱若薇, 麦益颖, 等. 儿童脑肿瘤治疗历史、现状及展望[J]. 中国现代神经疾病杂志, 2020, 20(4): 258-262.
4 王鑫, 王凯, 艾林. 脑胶质瘤11C-MET PET-CT成像的研究进展[J]. 中华神经外科杂志, 2018, 34(10): 1073-1076.
5 Warburg O. On the origin of cancer cells [J]. Science, 1956, 123(3191): 309-314.
6 Chiaravalloti A, Filippi L, Ricci M, et al. Molecular imaging in pediatric brain tumors[J]. Cancers (Basel), 2019, 11(12): E1853.
7 胡彬, 胡海勇. 18F-FET PET显像在脑胶质瘤诊断中的临床应用进展[J]. 医疗卫生装备, 2018, 39(6): 96-101.
8 王静楠, 罗亚平, 霍力, 等. 18F-DOPA PET/CT显像的研究进展[J]. 中华核医学与分子影像杂志, 2020, 40(2): 113-117.
9 O' Tuama LA, Phillips PC, Strauss LC, et al. Two-phase 11C L-methionine PET in childhood brain tumors[J]. Pediatr Neurol, 1990, 6(3): 163-170.
10 Utriainen M, Mets?honkala L, Salmi TT, et al. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography[J]. Cancer, 2002, 95(6): 1376-1386.
11 Phi JH, Paeng JC, Lee HS, et al. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet[J]. J Nucl Med, 2010, 51(5): 728-734.
12 Kaplan AM, Lawson MA, Spataro J, et al. Positron emission tomography using [18F] fluorodeoxyglucose and [11C] L-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors[J]. J Child Neurol, 1999, 14(10): 673-677.
13 Rosenberg DS, Demarquay G, Jouvet A, et al. [11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms[J]. J Neurol Neurosurg Psychiatry, 2005, 76(12): 1686-1692.
14 周惠君, 董萍, 沈国华, 等. 11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值[J]. 国际放射医学核医学杂志, 2015, 39(2): 161-164.
15 Dunkl V, Cleff C, Stoffels G, et al. The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents[J]. J Nucl Med, 2015, 56(1): 88-92.
16 Morana G, Piccardo A, Milanaccio C, et al. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study[J]. J Nucl Med, 2014, 55(5): 718-723.
17 Morana G, Piccardo A, Puntoni M, et al. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study[J]. Neuro Oncol, 2015, 17(12): 1637-1647.
18 Piccardo A, Tortora D, Mascelli S, et al. Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas[J]. Eur J Nucl Med Mol Imaging, 2019, 46(8): 1685-1694.
19 Morana G, Puntoni M, Garrè ML, et al. Ability of 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI to assess striatal involvement in paediatric glioma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(9): 1664-1672.
20 Pirotte BJ, Lubansu A, Massager N, et al. Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors[J]. J Neurosurg Pediatr, 2010, 5(5): 486-499.
21 Pirotte B, Acerbi F, Lubansu A, et al. PET imaging in the surgical management of pediatric brain tumors[J]. Childs Nerv Syst, 2007, 23(7): 739-751.
22 Messing-Jünger AM, Floeth FW, Pauleit D, et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas[J]. Childs Nerv Syst, 2002, 18(8): 445-449.
23 Lucas JT Jr, Serrano N, Kim H, et al. 11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma[J]. J Neurooncol, 2017, 132(1): 163-170.
24 Tinkle CL, Duncan EC, Doubrovin M, et al. Evaluation of 11C-methionine PET and anatomic MRI associations in diffuse intrinsic pontine glioma[J]. J Nucl Med, 2019, 60(3): 312-319.
25 Morana G, Piccardo A, Tortora D, et al. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET[J]. Eur J Nucl Med Mol Imaging, 2017, 44(12): 2084-2093.
26 Pirotte B, Levivier M, Morelli D, et al. Positron emission tomography for the early postsurgical evaluation of pediatric brain tumors[J]. Childs Nerv Syst, 2005, 21(4): 294-300.
27 Gauvain K, Ponisio MR, Barone A, et al. 18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors[J]. Neurooncol Pract, 2018, 5(1): 28-36.
文章导航

/